Αποτελέσματα 1 έως 15 από 15
Τύπος | Ημερομηνία | Τίτλος | Δημιουργός | Πλήρες κείμενο |
| 2013 | Insights into AT1 Receptor Activation through AngII Binding Studies | Matsoukas M.-T.; Potamitis C.; Plotas P.; Androutsou M.-E.; Agelis G.; Matsoukas J.; Zoumpoulakis P. | |
| 2013 | Molecular insights into the AT1 antagonism based on biophysical and in silico studies of telmisartan | Kritsi E.; Potamitis C.; Durdagi S.; Zoumpoulakis P.; Golic Grdadolnik S.; Mavromoustakos T. | |
| 2013 | New insights into the chemical and isotopic composition of human-body biominerals. I: Cholesterol gallstones from England and Greece | Athanasiadou D.; Godelitsas A.; Sokaras D.; Karydas A.-G.; Dotsika E.; Potamitis C.; Zervou M.; Xanthos S.; Chatzitheodoridis E.; Gooi H.C.; Becker U. | |
| 2014 | Structure-based design of inhibitors of the aspartic protease endothiapepsin by exploiting dynamic combinatorial chemistry | Mondal M.; Radeva N.; Köster H.; Park A.; Potamitis C.; Zervou M.; Klebe G.; Hirsch A.K.H. | |
| 2014 | An efficient synthetic method and theoretical calculations of olmesartan methyl ether: Study of biological function of AT1 antagonism | Ntountaniotis D.; Agelis G.; Resvani A.; Halabalaki M.; Liapakis G.; Spyridaki K.; Golic Grdadolnik S.; Merzel F.; Kostidis S.; Potamitis C.; Tselios T.; Matsoukas J.; Skaltsounis L.A.; Mavromoustakos T. | |
| 2014 | Insights into the molecular basis of action of the AT1 antagonist losartan using a combined NMR spectroscopy and computational approach | Zervou M.; Cournia Z.; Potamitis C.; Patargias G.; Durdagi S.; Grdadolnik S.G.; Mavromoustakos T. | |
| 2016 | Exploring new scaffolds for angiotensin II receptor antagonism | Kritsi E.; Matsoukas M.-T.; Potamitis C.; Karageorgos V.; Detsi A.; Magafa V.; Liapakis G.; Mavromoustakos T.; Zoumpoulakis P. | |
| 2016 | 2, 2′-Dihydroxybenzophenones and Derivatives. Efficient Synthesis and Structure Endoscopy by DFT and NMR. Credentials as Potent Antiinflammatory Agents | Tzeli, D.; Kozielewicz P.; Zervou M.; Potamitis C.; Kokkotou K.; Rak B.; Petrou A.; Tsolaki E.; Gavalas A.; Geronikaki A.; Petsalakis I.D.; Tsoungas P.G. | |
| 2016 | The crystal structure of the AgamOBP1•Icaridin complex reveals alternative binding modes and stereo-selective repellent recognition | Drakou C.E.; Tsitsanou K.E.; Potamitis C.; Fessas D.; Zervou M.; Zographos S.E. | |
| 2016 | Leveraging NMR and X-ray data of the free ligands to build better drugs targeting angiotensin II Type 1 G-Protein coupled receptor | Kellici T.F.; Ntountaniotis D.; Kritsi E.; Zervou M.; Zoumpoulakis P.; Potamitis C.; Durdagi S.; Salmas R.E.; Ergun G.; Gokdemir E.; Halabalaki M.; Gerothanassis I.P.; Liapakis G.; Tzakos A.G.; Mavromoustakos T. | |
| 2016 | BNN27, a 17-spiroepoxy steroid derivative, interacts with and activates p75 neurotrophin receptor, rescuing cerebellar granule neurons from apoptosis | Pediaditakis I.; Kourgiantaki A.; Prousis K.C.; Potamitis C.; Xanthopoulos K.P.; Zervou M.; Calogeropoulou T.; Charalampopoulos I.; Gravanis A. | |
| 2017 | Platinum complexes with a methoxy-amino phosphine or a nitrogen-containing bis(phosphine) ligand. Synthesis, characterization and application to hydrogenation of trans-cinnamaldehyde | Kostas I.D.; Antonopoulou G.; Potamitis C.; Raptopoulou C.P.; Psycharis V. | |
| 2019 | Synthesis and anticancer activity of novel 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives | Charitos G.; Trafalis D.T.; Dalezis P.; Potamitis C.; Sarli V.; Zoumpoulakis P.; Camoutsis C. | |
| 2019 | Novel hit compounds as putative antifungals: The Case of Aspergillus fumigatus | Kritsi E.; Matsoukas M.-T.; Potamitis C.; Detsi A.; Ivanov M.; Sokovic M.; Zoumpoulakis P. | |
| 2019 | Discovery of New non-steroidal selective glucocorticoid receptor agonists | Potamitis C.; Siakouli D.; Papavasileiou K.D.; Boulaka A.; Ganou V.; Roussaki M.; Calogeropoulou T.; Zoumpoulakis P.; Alexis M.N.; Zervou M.; Mitsiou D.J. | |